Dr. Schmitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St NE
Fl 11
Atlanta, GA 30308Phone+1 404-778-1900Fax+1 404-778-1251
Education & Training
- University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2006 - 2013
- University of WashingtonResidency, Surgery, 2006 - 2008
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- GA State Medical License 2019 - 2025
- MD State Medical License 2015 - 2021
- PA State Medical License 2013 - 2016
- WA State Medical License 2006 - 2013
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Clinical Trials
- Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer Start of enrollment: 2022 Feb 17
Roles: Contact, Principal Investigator
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Start of enrollment: 2024 Jun 26
Roles: Contact
Publications & Presentations
PubMed
- 127 citationsCisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell CarcinomaLinda Tran, Clint T. Allen, Roy Xiao, Ellen C. Moore, Ruth J. Davis
Cancer Immunology Research. 2017-11-02 - 29 citationsT cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic responseBenjamin A. Kansy, Gulidanna Shayan, Hyun-Bae Jie, Sandra P. Gibson, Yu Lei
Oncoimmunology. 2018-08-24 - 162 citationsInhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt
Clinical Cancer Research. 2020-03-15
Journal Articles
- Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct CarcinomasLisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
- Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell CarcinomaNicole C Schmitt, Clint T Allen, Clinical Cancer Research
Press Mentions
- WashU ENT Has Strong Presence at Annual AAO-HNSF MeetingAugust 30th, 2022
- Subtype-Specific Responses of hKv7.4 and hKv7.5 Channels to Polyunsaturated Fatty Acids Reveal an Unconventional Modulatory Site and MechanismJune 1st, 2022
- Research Roundup: Recent Grants and Publications for Emory Faculty and StaffSeptember 21st, 2021
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: